Expression and purification of the RPTPµ ectodomain. The extracellular region of human RPTPµ (termed eRPTPµ residues 1-742, GenBank entry NP_002836), fused Cterminally with a hexahistidine tag, was cloned into the pLEXm vector and expressed by transient transfection in HEK-293S GnTI-cells as described previously (1). Four days posttransfection conditioned medium was collected and the protein was purified on NiSepharose (Amersham Biosciences) followed by size-exclusion chromatography. Before crystallization, the construct was deglycosylated by treatment with endoglycosidase H f (New England Biolabs, 40,000 NEB units per mg RPTPµ) for 6 hours at 37˚C and purified once more by gel filtration in buffer containing 10mM HEPES, pH 7.4, 150 mM NaCl.
Crystallization and structure determination. Prior to crystallization the protein was concentrated to 3.6 mg/ml in gel filtration buffer. Sitting drop vapour diffusion crystallization trials were carried out using a Cartesian Technologies pipetting robot to set up nano-crystallization consisting of 100 nl protein solution and 100 nl reservoir solution in 96-well Greiner plates (2). Crystallization plates were placed in a TAP Homebase storage vault maintained at 295 K and imaged via a Veeco visualization system (3). eRPTPµ crystallized out of a mother liquor containing Polyethylene Glycol SMEAR (4) 22.5 % w-v (a mixture of equal volumes of 50% w/v stock solutions of ten polyethylene glycol polymers with the following molecular weights: 200, 400, 600, 1000, 1500, 3000, 4000, 6000, 8000 and 10000 Da), 100 mM bis-Tris Propane, pH 6.5 and 200 mM Potassium Thiocyanate. Crystals were cryo-protected in perfluoropolyether oil PFO-X125/03 (Lancaster Synthesis) and diffracted to 3.1 Å after flash-freezing at 100 K on beamline ID29 at the ESRF, France. X-ray data were processed and scaled with the HKL suite (5).
The program XPREP (http://www.bruker-nonius.com) was used to calculate quality indicators and to merge data. Crystallographic statistics are shown in Supporting Table S1 .
The eRPTPµ crystal structure was determined using the molecular replacement method. In the first step the position of the MIg region was identified using program PHASER (6) with the RPTPµ MAM-Ig structure (PDB accession code 2C9A (7)) as search model. In the next steps the positions of the FN2 and FN3 domains were solved with program MOLREP (8) fixing the previously identified position of the MAM-Ig. Search models for the FN2 and FN3 domains were generated using the homology modelling server 3D-PSSM (http://www.sbg.bio.ic.ac.uk/3dpssm/). Rigid body refinement and simulated annealing using the program CNS (9) resulted in an electron density map of high quality and allowed manual building of the missing FN1 domain. Iterative cycles of refinement in CNS and REFMAC (10), and manual building in COOT (11) Table S1 gives the crystallographic statistics.
The stereochemical properties were assessed by PROCHECK (13) and WHATCHECK (14). Superpositions were calculated using the program SHP (15).
Cell adhesion assays. EGFP-tagged RPTPµ constructs were based on Exµ-TM-EGFP, as previously described (7). Site-directed mutants were created by two-step PCR and verified by DNA sequencing. The Bac-to-Bac system (Invitrogen) was used to produce recombinant baculoviruses and normally non-aggregating insect Sf9 cells were used for cell adhesion assays as described (7, 16, 17) . Cells were visualised live, 40-48 hours post-infection, using an inverted microscope equipped with epifluorescence (Nikon DIAPHOT 300).
Transmission electron microscopy. The minimal RPTPµ ectodomain construct that can mediate cell adhesion consists of the MAM, Ig, FN1 and FN2 domains (7). This, as well as progressively longer constructs (obtained by addition of the FN3 or containing the full length ectodomain, respectively) were expressed in a transmembrane form (fused with the RPTPµ transmembrane and intracellular region from which the second PTP catalytic domain was replaced with EGFP (7)) on the Sf9 cell surface and adhesion assays performed as described above. For intermembrane distance measurements, cell aggregates were fixed in a mixture of 2.5% glutaraldehyde and 2 % formaldehyde, post-fixed in buffered 1% osmium tetroxide, and embedded in epon resin as described (18). Thin sections were examined using a Phillips Technai G2 Electron Microscope equipped with a cooled CCD camera. Digital images of interfaces were captured at x43,500 magnification using integrated Soft Imaging Software (SIS) (GmbH, Munster, Germany) and measurements recorded directly from images. Intermembrane distances were measured from interface regions where apposed cell membranes were aligned and exhibited a trilaminar appearance, indicating that they were orthogonal to the imaging plane. For presentation, pictures were taken (at x49,000 final magnification) using Kodak photographic film and the negatives subsequently scanned and recorded digitally (2400dpi).
Immunolabelling. Cell aggregates expressing the full RPTPµ ectodomain construct described above were fixed for 1 hour in 8% paraformaldehyde in 250 mM Hepes buffer (pH 7.4). Following a 2 hours incubation at 4ºC, cells were washed in 250 mM Hepes, pelleted in 2% gelatin/PBS and incubated at 4ºC. Once hardened samples were washed in Hepes buffer and infused with 2.3M sucrose overnight at 4ºC. Sucrose-infused samples were cut into small cubes, mounted on holders and frozen in liquid nitrogen. Samples were cut using an ultramicrotome under liquid nitrogen and cryosections were collected on formvar-coated nickel grids. Following quenching in 250 mM Hepes containing 20 mM glycine, grids were washed in Hepes buffer-1% BSA and labeled with 10µg/ml rabbit anti-GFP polyclonal antibody (Millipore, UK) for 1 hour. Samples were then washed and labeled for 1 hour with an anti-rabbit-10 nm gold conjugated secondary antibody (Abcam, UK) at 1:25 dilution. All steps were performed at room temperature. Grids were thoroughly washed and transferred onto drops of 1.8% aqueous methyl cellulose containing 0.2% aqueous uranyl acetate and cooled on ice for 10 min. Excess methyl cellulose was blotted off and grids left to dry. When dry, grids were examined as described in Transmission electron microscopy.
Illustrations. Figures were produced using the programs PYMOL (www.pymol.org), Adobe Photoshop (Adobe Systems) and Corel Draw (Corel Corporation). In the other three panels eRPTPµ is depicted in grey with the closest structural homologues (identified using a secondary structure matching server at the EBI (19)) superimposed on the structure. The second panel from the left shows a superposition with the MIg structure (pdb accession code 2C9A, rmsd 1.0 Å for 255 Cα equivalents). The third panel from the left presents superpositions of the closest hits found using the single FN domains as search templates (orange: 5 th FNIII domain of human Protein 3A, pdb code 2CRZ, rmsd 1.6 Å for 91 Cα equivalents, sequence identity 19%; blue: 3 rd fibronectin III domain of human KIAA0343, pdb code 1UEN, rmsd 2.1 Å for 96 Cα equivalents, sequence identity 17%; green: 3 rd fibronectin III repeat of human Tenascin, pdb code 1TEN, rmsd 1.4 Å for 83 Cα equivalents, sequence identity 22%). The right hand panel shows the superposition with the tandem repeats of the cytoplasmic tail of integrin α6β4 (PDB 1QG3, rmsd: 2.1 Å for 170 Cα equivalents; see main text). (B) Superposition of eRPTPµ (grey) with the MIg structure (7) which is coloured red where there are significant differences between the structures whereas blue parts are superimposable (significance level defined by default criteria of program ESCET (20)). The rigid body movement of the Ig domain is indicated. The L1 and L2 loops, analysed previously (7), are highlighted by dotted circles. These are not involved in the formation of the trans adhesive interface described in this manuscript but previous results suggest that L2 is involved in cis interactions (21). (C) Surface representation of the FN2 and FN3 domains of eRPTPµ, highlighting areas of conserved surface residues between RPTPµ and the tandem repeats of the cytoplasmic tail of integrin α6β4. Conserved residues are colored red, non-conserved in white. Numbering is that of the full length human RPTPµ (including the secretion signal). Secondary structure assignments for eRPTPµ are displayed in green above the alignments. Observed domain boundaries are marked by black arrows. Accessibilities of eRPTPµ residues are given below the alignments (blue, accessible, cyan, intermediate; white, buried) . Following refinement, clear electron density corresponding to the N-linked N-acetylglucosamine (GlcNAc) could be seen at seven out of the twelve glycosylation sites predicted by the NetNGlyc server (http://www.cbs.dtu.dk/services/NetNGlyc/): N72, N92, N131, N406, N414, N454 and N544 (marked by filled orange hexagons). An additional site, N249, may also be occupied, but the electron density is inconclusive (yellow-filled orange hexagon). Finally, no sugar density could be seen at N534 (open orange hexagon), while 3 remaining sites are located in the disordered FN4 domain (grey-filled orange hexagon). (B) Representation of the eRPTPµ dimer. One monomer is depicted as black ribbons, the other as solvent accessible surface, highlighting areas of conserved residues. The conservation of the surface residues, based on the 24 sequences used for the sequence alignment in (A), is represented from white to red (red is 100%) according to the colour scale. The right panel is rotated around the y axis 90° in relation to the left panel. The green box indicates the highly conserved and exposed surface formed by the FN1 and FN2 domains. The blue box highlights the conserved residues contributing to the dimer interface. Fig. S4 . Gel filtration of eRPTPµ and mutant constructs. Soluble, secreted constructs transiently expressed in HEK293T cells were analyzed on a Sephadex 200 30/10 column at pH 8.0 (red trace) and pH 5.5 (blue trace, height adjusted against the pH 8 trace). Previous studies have described the pH-dependent dimerisation of eRPTPµ (7, 21) . The dimer and monomer peaks are indicated by "D" and "M" symbols, respectively. Residues conserved between RPTPµ and RPTPk (54% sequence identity) are in red and listed, nonconserved, residues contributing to the dimer interface are in blue. (B) Mapping of RPTPρ mutations identified in colorectal cancers (24). Equivalent RPTPµ residues are shown as black spheres. Differences in numbering are due to a longer secretion signal in RPTPρ. Three mutations affect residues contributing to the hydrophobic core of the MAM and Ig domains (F74S, A209T and F248S) and are likely to disrupt the domain fold. Two other mutations (Y280H and Y412F) are positioned at interdomain junctions and may perturb the rigidity of the ectodomain. A third group of mutations, K218T and N510K, are exposed on the molecular surface. Their effect remains unaccounted for by the structure of the trans homodimer, as does the role of a highly conserved group of residues identified on the surface between the FN1 and FN2 domains ( fig. S3, B) . These latter observations are suggestive of RPTP ectodomains being involved in additional interactions. There is evidence that RPTPµ molecules can form homophilic contacts beyond the primary trans interaction, possibly in a cis orientation (7, 21), but they may also participate in heterophilic interactions. Thus the cancerrelated ectodomain mutations appear to exert their effects via several different mechanisms. 
